Loading...

Loading...

Turning Nature’s Foes Into Personalized Cancer Vaccines
By Luis Alberto Velez - Wed, 09/24/2025 - 06:30
Oncolytic viruses are a new frontier in personalized oncology, using reprogrammed viruses to destroy cancer cells. Luis Velez explains,
https://mexicobusiness.news/tag/gene-therapy
More Health
Genprex Secures US, EU Patents for its Oncology Drug Reqorsa
By MBN Staff - Mon, 08/18/2025 - 14:24
Genprex received US and EU patent allowances for Reqorsa therapy in combination with PD-1 and PD-L1 antibodies, extending protection to 2037.
Precision Medicine Market Grows in Mexico
By Sofía Garduño - Tue, 07/01/2025 - 11:06
Mexico is advancing in personalized medicine, driven by AI, gene therapies, and precision oncology, amid growing market opportunities and challenges.
CAR-T Cell Therapy: The New Frontier in Personalized Cancer Care
By Luis Alberto Velez - Thu, 06/12/2025 - 07:00
CAR-T therapy is transforming cancer care, with personalized, powerful, and adaptive treatments now expanding in Mexico, writes Luis Alberto Velez.
INCan Highlights Progress in Blood Cancer Therapies
By MBN Staff - Mon, 06/09/2025 - 09:52
New therapies are improving outcomes for blood cancer patients in Mexico, with INCan emphasizing early detection and modern treatment options.
Marken Rebrands to Boost Global Healthcare Logistics
By Sofía Garduño - Fri, 02/21/2025 - 15:38
Marken rebrands as UPS Healthcare Precision Logistics, uniting Marken,MNX, and Polar Speed to enhance global healthcare logistics and patient access

Gene, Cell Therapy Coverage Could be the Next Employee Benefits
By Sofía Garduño - Mon, 01/20/2025 - 16:00
Some employers are considering including gene and cell therapies as part of employee benefits, but there are challenges in the way, says IBI.

AI and Genetics: The Future of Health Is Individualized
By Gustavo Rodríguez Leal - Mon, 12/09/2024 - 14:00
Decoding our DNA and pairing it with AI-driven insights will lead to healthcare that is more precise, and accessible, writes Gustavo Rodriguz Leal.

Improving Mexico’s Approach to Rare Diseases
By Sofía Garduño - Fri, 10/25/2024 - 12:17
Mexico could improve rare disease care by increasing healthcare investment and adopting a multidisciplinary approach, says BioMarin’s David López.
BioMarin to Cut 225 Jobs in Global Reorganization
By MBN Staff - Tue, 09/03/2024 - 09:03
BioMarin cuts 225 jobs in a global reorganization after halting gene therapy developments and implementing strategic shifts.